0001437749-22-027949.txt : 20221123 0001437749-22-027949.hdr.sgml : 20221123 20221123083028 ACCESSION NUMBER: 0001437749-22-027949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221121 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEMP WALTER V CENTRAL INDEX KEY: 0000938419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 221412368 MAIL ADDRESS: STREET 1: 1415 WEST LOOP NORTH CITY: HOUSTON STATE: TX ZIP: 77055 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 4 1 rdgdoc.xml FORM 4 X0306 4 2022-11-21 0001659617 Moleculin Biotech, Inc. MBRX 0000938419 KLEMP WALTER V C/O MOLECULIN BIOTECH, INC. 5300 MEMORIAL DR., SUITE 950 HOUSTON TX 77007 1 1 CEO and President Common Stock 2022-11-21 4 P 0 22500 1.1496 A 364890 D This transaction was executed in multiple trades at prices ranging from $1.12 to $1.17. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Jonathan P. Foster by Power of Attorney 2022-11-23